Pre-Clinical in Vitro and in Vivo Evidence for Plausible Mechanisms Underlying the Risk of Cancer Associated with Insulin and Insulin Analogues.

Conclusion: In general many studies on pre-clinical in vitro and in vivo evidence for plausible mechanisms underlying the risk of cancer associated with insulin and insulin analogues exist. However, the level of evidence or a causal association between insulin and insulin analogues and cancer is low. PMID: 24215309 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24215309?dopt=Abstract

Source: Current Drug Safety - November 7, 2013 Category: Drugs & Pharmacology Authors: Vestergaard P, Starup-Linde J Tags: Curr Drug Saf Source Type: research